Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...

India's economy surged past expectations, posting an impressive 8.2% real GDP growth in the second quarter of FY 2025-26, the ...

This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...

Whooping cough, a bacterial infection that can be especially dangerous for babies and young children, is on the rise. As of ...

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive final immunogenicity and safety data from Phase 2 study, VLA15-221, of Lyme disease vaccine candidate, VLA15. The results showed ...

SpaceX Starship 25 and Super Heavy booster 9 launched to orbit from the Starbase facility in South Texas. Following the ...

A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...

Valneva said that antibody levels remained well above baseline across all six Lyme disease serotypes and all age groups in ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) The Conversation asked epidemiologist Annette Regan to explain why pertussis has ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

Valneva SE (NASDAQ:VALN) saw its stock move higher on Wednesday after the company released final Phase II results for its Lyme disease vaccine candidate, VLA15, showing robust immune responses ...